<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/102</identifier>
				<datestamp>2024-10-30T18:33:51Z</datestamp>
				<setSpec>aavptbiennial:S4</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Intravenous Insulin Infusion</dc:title>
	<dc:creator xml:lang="en">Schall, William D.</dc:creator>
	<dc:subject xml:lang="en">Ketoacidosis</dc:subject>
	<dc:subject xml:lang="en">insulin dosage</dc:subject>
	<dc:subject xml:lang="en">low dose infusion</dc:subject>
	<dc:subject xml:lang="en">intravenous injection</dc:subject>
	<dc:description xml:lang="en">Diabetic Ketoacidosis has traditionally been treated by intermittent intravenous bolus administration of regular insulin. Recently, the efficacy and convenience of low dose intravenous insulin infusion has been reported as used in man and dogs. The advantages of low dose infusion in man compared to intermittent intravenous injection have been reported.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1978-03-13</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/102</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; First Symposium; 236-237</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/102/96</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1978 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
